Results 241 to 250 of about 105,303 (279)

Development and validation of a nutrition risk screening for patients with childhood cancer in Brazil (NUTRICCAN)

Nutrition in Clinical Practice, EarlyView.
Abstract Background Diagnosing malnutrition in patients with pediatric cancer is challenging because tumor masses can interfere with anthropometric measurements. STRONGkids considers cancer a general risk factor, whereas Screening Tool for Childhood Cancer (SCAN) classifies patients as at risk or not, potentially missing those who need nutrition ...
Cristiane Ferreira Marçon, Carolina Araújo dos Santos, Fernanda Luisa Ceragioli Oliveira   +2 more
wiley   +1 more source

Immunophenotypic and molecular comparison between allogeneic and autologous graft‐vs‐host disease of the skin: A retrospective study using immunohistochemical and proteomics methods

, 2017
Julia S. Lehman, Shahrukh K. Hashmi, Hillard M. Lazarus, Rokea A. el‐Azhary, Lawrence E. Gibson, William J. Hogan, Mark R. Litzow, Mrinal M. Patnaik, Francis K. Buadi, Martha Q. Lacy, Surendra Dasari, Patrick M. Vanderboom, Alexander Meves   +12 more
openalex   +2 more sources

Patterns of parenteral nutrition use in the inpatient setting: A retrospective cohort study

Nutrition in Clinical Practice, EarlyView.
Abstract Background Parenteral nutrition (PN) supports patients unable to absorb sufficient nutrients from their gastrointestinal tracts. Yet, information about the patterns and extent of PN's in‐hospital use is lacking. Data on this topic should provide comparison points for nutrition support teams and hospital administrators examining PN use in their
Marc Romain, Charles Weissman, Khuloud Abu‐Tair, Abdallah Alla Aldin, Rivki Harari, Orit Bitner, Alexander Furmanov, Shaul Yaari   +7 more
wiley   +1 more source

Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease.

JAMA Dermatol
Baumrin E, Shin DB, Mitra N, Pidala J, El Jurdi N, Lee SJ, Loren AW, Gelfand JM.   +7 more
europepmc   +1 more source

GM-CSF Promotes the Expansion and Differentiation of Cord Blood Myeloid-Derived Suppressor Cells, Which Attenuate Xenogeneic Graft-vs.-Host Disease

, 2019
Mi-Young Park, Bang-Geul Lim, Su‐Yeon Kim, Hyun‐Jung Sohn, Sueon Kim, Tai‐Gyu Kim   +5 more
openalex   +1 more source

Fetal Diagnosis of Hypoplastic Left Heart Syndrome With Restrictive Atrial Septum—Atrial Septal Morphology, Associated Lung Disease and Outcomes

Prenatal Diagnosis, EarlyView.
ABSTRACT Objective Fetuses with hypoplastic left heart syndrome (HLHS) and restrictive/intact atrial septum (RAS) have high mortality, partly due to pulmonary lymphangiectasia (PL). This study aimed to characterize atrial septal morphology in fetuses with HLHS and RAS and evaluate the impact of fetal intervention on PL and outcomes.
Sofie Dannesbo, Gloria Ho, Mike Seed, Vitor Guerra, Rajiv Chaturvedi, Andrew C. Cook, Niels Vejlstrup, Kasper Iversen, Henning Bundgaard, Lindsay R. Freud   +9 more
wiley   +1 more source

Mesenchymal stromal cells in the treatment of pediatric hematopoietic cell transplantation-related complications (graft vs. host disease, hemorrhagic cystitis, graft failure and poor graft function): a single center experience. [PDF]

Front Pediatr
Pérez-Torres Lobato M, Benitez-Carabante MI, Alonso L, Torrents S, Castillo Flores N, Uria Oficialdegui ML, Panesso M, Alonso-Martínez C, Oliveras M, Renedo-Miró B, Vives J, Diaz-de-Heredia C.   +11 more
europepmc   +1 more source

Mesenchymal stromal cell therapy for rheumatoid arthritis: Long‐term efficacy, safety, and mechanistic insights

Rheumatology &Autoimmunity, EarlyView.
Graphical abstract summarizing the multifactorial pathogenesis of rheumatoid arthritis (RA) and the therapeutic potential of mesenchymal stromal cell (MSC) therapy. MSCs provide promising benefits through their immunomodulatory properties, low immunogenicity, ability to promote tissue repair, and multi‐lineage differentiation, presenting a potential ...
Yingjia Chen, Ruiyu Gao, Xing Guo, Genhong Yao, Xiaojun Tang, Yile E. Liu, Lingyun Sun   +6 more
wiley   +1 more source

Have we made progress in the management of chronic graft-vs-host disease?

, 2010
Stephanie J. Lee
openalex   +2 more sources